Alnylam Pharmaceuticals Inc.
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2008 | $96.2M | $-27.8M | $-26.2M |
| FY2009 | $100.5M | $-48.1M | $-47.6M |
| FY2010 | $100.0M | $-44.1M | $-43.5M |
| FY2011 | — | $-54.8M | $-57.6M |
| FY2012 | — | $-129.5M | $-106.0M |
| FY2013 | — | $-92.9M | $-89.2M |
| FY2014 | — | $-405.0M | $-360.4M |
| FY2015 | — | $-296.0M | $-290.1M |
| FY2016 | $47.2M | $-424.6M | $-410.1M |
| FY2017 | $89.9M | $-500.1M | $-490.9M |
| FY2018 | $74.9M | $-814.7M | $-761.5M |
| FY2019 | $219.8M | $-939.4M | $-886.1M |
| FY2020 | $492.9M | $-828.4M | $-858.3M |
| FY2021 | $844.3M | $-708.7M | $-852.8M |
| FY2022 | $1.04B | $-785.1M | $-1.13B |
| FY2023 | $1.83B | $-282.2M | $-440.2M |
| FY2024 | $2.25B | $-176.9M | $-278.2M |
| FY2025 | $3.71B | $501.6M | $313.7M |